6:20 PM
 | 
Oct 23, 2012
 |  BC Extra  |  Financial News

Amgen beats Street, raises guidance

Amgen Inc. (NASDAQ:AMGN) increased its full-year revenue and EPS guidance after reporting a 3Q12 adjusted diluted EPS of $1.67, beating the Street's estimate by $0.20 and up 19% from $1.40 in...

Read the full 139 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >